An interleukin-2 receptor gamma chain mutation with normal thymus morphology

J Clin Invest. 1997 Dec 15;100(12):3036-43. doi: 10.1172/JCI119858.

Abstract

One of the most common human immunodeficiencies is an X-linked condition arising from mutations of the gamma subunit of the interleukin-2 receptor (IL-2Rgamma). The IL-2Rgamma protein is one chain of the heterotrimeric (alpha, beta, gamma) IL-2 receptor, but also participates in the formation of the IL-4, 7, 9, and 15 receptor complexes. The diagnosis of X-linked SCID is usually relatively simple due to the distinctive immunological presentation; IL-2Rgamma-deficient patients typically lacking mature T lymphocytes (T-B+). However, it is becoming clear that this merely represents one extreme of a potential range of clinical presentations. We describe here a novel mutation of the human IL-2Rgamma chain (R222C) resulting in an unusual immunological phenotype. Although clinically immunodeficient, this patient has normal numbers of peripheral T and B cells, responds normally to mitogenic stimuli, and unusually, has a normal thymus gland. This IL-2Rgamma mutation is distinctive in that the protein is sufficiently stable to be expressed at the cell surface. While the T cell receptor repertoire appears complete, suggesting normal T cell differentiation occurs, patient T cells demonstrate a reduced ability to bind IL-2 and this appears sufficient to cause a deficiency in their ability to participate in antigenic responses. Early clinical recognition of this phenotype is critical as a delay in diagnosis may result in a fatal infection.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COS Cells
  • Humans
  • Infant
  • Janus Kinase 3
  • Ligands
  • Male
  • Mutation
  • Protein-Tyrosine Kinases / metabolism
  • Receptors, Interleukin-2 / genetics*
  • Receptors, Interleukin-2 / metabolism
  • Severe Combined Immunodeficiency / genetics*
  • Severe Combined Immunodeficiency / immunology
  • Severe Combined Immunodeficiency / metabolism
  • Severe Combined Immunodeficiency / pathology
  • Thymus Gland / immunology
  • Thymus Gland / pathology*

Substances

  • Ligands
  • Receptors, Interleukin-2
  • Protein-Tyrosine Kinases
  • JAK3 protein, human
  • Janus Kinase 3